MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Clinical and Imaging features of Hyperkinetic Movement Disorders related with Stroke

    H. Valdez Ruvalcaba, H. Martinez, G. Chac Lezama, F. de Leon, H. Pacheco Mendoza, V. Cano Nigenda, L. Alvarez, A. Arauz, A. Medina-Islas (mexico, Mexico)

    Objective: To describe the characteristics of hyperkinetic movement disorders in patients with stroke. Background: Movement disorders (MD) related to cerebrovascular disease represent 22% of all…
  • 2022 International Congress

    α-Synuclein molecular behavior and proteomic profiling distinguish subtypes of Lewy body disorders

    I. Martinez-Valbuena, E. Swinkin, E. Santamaria Martinez, J. Fernandez-Irigoyen, V. Sackmann, A. Kim, P. Gonzalez-Latapi, G. Kuhlman, S. Bhowmick, NP. Visanji, AE. Lang, GG. Kovacs (Toronto, Canada)

    Objective: We hypothesized that the clinical heterogeneity found in Lewy body disorders is a consequence of the molecular diversity of αSyn between different patients as…
  • 2022 International Congress

    The effect of short-term treadmill exercise in the alpha-synuclein preformed fibril rat model of Parkinson’s disease

    S. Fleming, J. Patterson, C. Kemp, J. Lepp, E. Hamad, S. Scott, J. Holden, A. Davis, C. Szarowicz, J. Lipton, M. Kubik, N. Kuhn, A. Stoll, K. Luk, C. Sortwell (Rootstown, USA)

    Objective: To determine how treadmill exercise impacts behavior and Parkinson-related pathology in the alpha-synuclein (a-syn) preformed fibril (PFF) model. Background: Exercise is often recommended by…
  • 2022 International Congress

    Hidden effects of COVID-19 pandemic on Parkinson’s Disease: a telemedicine survey

    V. Tommasini, C. Bertolotti, M. Catalan, P. Polverino, L. Antonutti, G. Bellavita, A. Cucca, M. Liccari, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to report the telemedicine experience of our Movement Disorder Unit during COVID-19 pandemic and to assess the clinical…
  • 2022 International Congress

    Quality of life changes after subthalamic stimulation for Parkinson’s disease depend on nonmotor and motor symptoms clusters

    L. Braun, S. Jost, M. Silverdale, A. Rizos, M. Santos Ghilardi, R. Cury, P. Loehrer, C. Nimsky, K. Ashkan, A. Sauerbier, A. Gronostay, G. Fink, M. Barbe, J. Evans, V. Visser-Vandewalle, E. Fonoff, A. Antonini, L. Timmermann, P. Martinez-Martin, K. Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To analyze quality of life (QoL) changes after subthalamic stimulation (STN-DBS) based on a short list of baseline nonmotor and motor symptoms in Parkinson’s…
  • 2022 International Congress

    The role of Parkinson Nurses for personalizing care in Parkinson’s Disease: a systematic review and meta-analysis

    J. Stümpel, M. van Munster, T. Mestre, D. Pedrosa (Cologne, Germany)

    Objective: To identify the various roles and functions that Parkinson Nurses (PNs) may hold for personalized care of Patients with Parkinson’s (PwPs). Providing a systematic…
  • 2022 International Congress

    Parkin deficiency impairs mtDNA dynamics and propagates inflammation

    K. Wasner, S. Smajić, J. Ghelfi, S. Delcambre, C. Prada-Medina, E. Knappe, G. Arena, P. Mulica, G. Agyeah, A. Rakovic, I. Boussaad, K. Badanjak, J. Ohnmacht, J. Gérardy, M. Takanashi, J. Trinh, M. Mittelbronn, N. Hattori, C. Klein, P. Antony, P. Seibler, M. Spielmann, S. Pereira, A. Grünewald (Belvaux, Luxembourg)

    Objective: We sought to explore Parkin’s role in (i) averting neuronal mtDNA dyshomeostasis/release and (ii) the activation of downstream inflammatory processes. Background: Mutations in Parkin…
  • 2022 International Congress

    Gene and variant curation of Parkinson’s disease genes by an authoritative expert panel

    J. Beck, K. Lohmann, L. Lange, A. Naito, A. Kumeh, C. Thaxton, M. Weaver, S. Strom, R. Alcalay (New York, USA)

    Objective: Establish an authoritative central curation for causative genes and variants for Parkinson’s disease (PD) Background: The urgency to establish central curation for causative genes…
  • 2022 International Congress

    Studies on stigma in Parkinson’s disease in the world. A literature review

    S. Kibrit, AV. Karacan, G. Kayis, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

    Objective: To demonstrate the geographical distribution of studies among populations, and to summarize factors associated with stigma in Parkinson’s disease (PD). Background: One of the…
  • 2022 International Congress

    A fully immersive virtual reality environment to study gait modulation in Parkinson’s disease

    I. Hanafi, P. Kullmann, IU. Isaias, C. Palmisano (Würzburg, Germany)

    Objective: To investigate the safety and efficacy of a fully immersive virtual reality (VR) paradigm to study gait modulation in subjects with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 795
  • 796
  • 797
  • 798
  • 799
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley